Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis

被引：0
|
作者：
D Cella
M D Michaelson
A G Bushmakin
J C Cappelleri
C Charbonneau
S T Kim
J Z Li
R J Motzer
机构：
[1] Robert H Lurie Comprehensive Cancer Center of Northwestern University,
[2] 710 N Lake Shore Dr.,undefined
[3] Chicago,undefined
[4] IL 60611,undefined
[5] USA,undefined
[6] Massachusetts General Hospital,undefined
[7] Cancer Center,undefined
[8] 55 Fruit Street,undefined
[9] YAW 7,undefined
[10] Boston,undefined
[11] MA 02114,undefined
[12] USA,undefined
[13] Pfizer Global Research and Development,undefined
[14] Pfizer Global Research and Development,undefined
[15] Pfizer Oncology,undefined
[16] La Jolla,undefined
[17] Memorial Sloan-Kettering Cancer Center,undefined
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：658 / 664
页数：6
相关论文
共 50 条
  • [1] Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis
    Cella, D.
    Michaelson, M. D.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Kim, S. T.
    Li, J. Z.
    Motzer, R. J.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (04) : 658 - 664
  • [2] Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: Results from a phase III randomized trial
    Cella, David
    Li, Jim Z.
    Cappelleri, Joseph C.
    Bushmakin, Andrew
    Charbonneau, Claudie
    Kim, Sindy T.
    Chen, Isan
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3763 - 3769
  • [3] Health-related quality of life in Japanese patients with metastatic renal cell carcinoma treated with sunitinib
    Hideaki Miyake
    Ken-ichi Harada
    Yuji Kusuda
    Masato Fujisawa
    [J]. International Journal of Clinical Oncology, 2013, 18 : 220 - 225
  • [4] Health-related quality of life in Japanese patients with metastatic renal cell carcinoma treated with sunitinib
    Miyake, Hideaki
    Harada, Ken-ichi
    Kusuda, Yuji
    Fujisawa, Masato
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) : 220 - 225
  • [5] Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α
    S Patil
    R A Figlin
    T E Hutson
    M D Michaelson
    S Negrier
    S T Kim
    X Huang
    R J Motzer
    [J]. British Journal of Cancer, 2012, 106 : 1587 - 1590
  • [6] Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α
    Patil, S.
    Figlin, R. A.
    Hutson, T. E.
    Michaelson, M. D.
    Negrier, S.
    Kim, S. T.
    Huang, X.
    Motzer, R. J.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (10) : 1587 - 1590
  • [7] Effects of sunitinib versus interferon-alfa in health-related quality of life in patients with metastatic renal cell carcinoma (MRCC): Results from a randomized multinational phase III trial
    Cella, D.
    Li, Jz
    Cappelleri, J. C.
    Bushmakin, A.
    Kim, S. T.
    Chen, I.
    Motzer, R. J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 238 - 238
  • [8] HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS RECEIVING SUNITINIB (SU) OR INTERFERON (IFN)-ALFA IN A RANDOMIZED PHASE III TRIAL: UPDATED GEOGRAPHIC ANALYSIS
    Cella, D.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Li, J. Z.
    Kim, S. T.
    Motzer, R. J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 189 - 189
  • [9] AN UPDATED GEOGRAPHIC SUBPOPULATION ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) ENROLLED IN A PHASE III TRIAL OF SUNITINIB VERSUS INTERFERON-ALFA
    Cella, D.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Kim, S. T.
    Motzer, R. J.
    Charbonneau, C.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A483 - A483
  • [10] Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma
    Motzer, Robert J.
    Hudes, Gary
    Wilding, George
    Schwartz, Lawrence H.
    Hariharan, Subramanian
    Kempin, Susan
    Fayyad, Rana
    Figlin, Robert A.
    [J]. CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 28 - 33
12345